Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Curis Inc CRIS

Sector: Healthcare | Sub-Sector: Biotechnology

Curis, Inc., is a drug discovery and development company. The Company is engaged in the development of its proprietary targeted cancer drug candidates, including CUDC-907, HDAC and phosphatidylinositol-3-kinase, or PI3K.
Price: $1.585 | Change: $-0.065 | %Change: -3.94%
Volume: 2.0m | Day High/Low: 1.654/1.53 | 52 Week High/Low: 4.74/1.53

Snapshot

Last Traded: August 22, 2014 12:00 Transaction Volume: 2.0m
Open: $1.585 Previous Close: $1.65
Bid: N/A Ask: N/A
Bid Size: 0 Ask Size: 0
Market Cap: $136.3m Shares Out: 86.0m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts